Stoke Therapeutics, Inc. ($STOK)
Allan Jonathan โ GENERAL COUNSEL & CORP SEC
Shares
4,222
Price
$31.28
Total Value
$132,080.20
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Transaction Details
| Insider | Allan Jonathan |
|---|---|
| Title | GENERAL COUNSEL & CORP SEC |
| Transaction Date | Mar 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 4,222 |
| Price per Share | $31.28 |
| Total Value | $132,080.20 |
| Shares Owned After | 29,242 |
| Derivative | No |
| Accession Number | 0001966716-26-000006 |
| Document | View SEC Filing |